GLP-1RA may open a new era for MASLD treatment: Editorial on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study”
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Association for the Study of the Liver
2026-04-01
|
| Seri Bilgileri: | Clinical and Molecular Hepatology |
| Konular: | |
| Online Erişim: | http://e-cmh.org/upload/pdf/cmh-2025-0628.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|